2026 —
Current
Integrated production–routing for radiopharmaceuticals
Supervised by Prof. Dr. Cleber Damião Rocco , School of Applied Sciences (FCA), Unicamp.
The MOPTA 2017 problem couples two decisions that are usually studied apart. A set of heterogeneous production lines makes a radioactive product whose usable dose decays from the moment it is produced; a fleet of vehicles must then deliver it to imaging centres, each of which has a fixed appointment schedule. A batch produced too early is worthless on arrival; a batch produced too late misses the window entirely.
The formulation is a production MIP coupled to a vehicle-routing subproblem with time windows, iterated on a production-time-deadline estimate. The naive coupling diverges — each iteration tightens the deadlines until almost no batch–appointment pair remains feasible — which is itself an interesting failure and the reason a principled decomposition is needed.
A survey across EJOR, Transportation Science and Omega confirms that no published work applies an exact or near-exact method to this problem: the radiopharmaceutical literature uses heuristics, and the exact production-routing literature does not model decay. The intended contribution is an ALNS scheme for the routing subproblem combined with Benders cuts from routing back into production.
Key references
- Lee et al., EJOR (2014) — nuclear medicine production and delivery
- Dayarian & Desaulniers, Transportation Science (2019) — branch-price-and-cut for short-lifespan production routing
- Arda et al., EJOR (2024) — home chemotherapy with stability windows